首页|期刊导航|老年心脏病学杂志(英文版)|Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial
Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial
Xiao-Si JIANG Zong-Zhuang LI Yong-Jun LI Ren-Qiang YANG Geng QIAN Yun-Dai CHEN Li-Chao TIAN Zi-Chao JIANG Yu-Ting ZOU Ping LI Xin-Chun YANG Xi SU Jin-Wen TIAN Bei SHI
老年心脏病学杂志(英文版)2020,Vol.17Issue(8):519-524,6.
老年心脏病学杂志(英文版)2020,Vol.17Issue(8):519-524,6.DOI:10.11909/j.issn.1671-5411.2020.08.002
Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial
Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial
摘要
关键词
Cardiovascular disease/Myocardial infarct size/Nicorandil/Primary percutaneous coronary intervention/ST-segment elevation myocardial infarctionKey words
Cardiovascular disease/Myocardial infarct size/Nicorandil/Primary percutaneous coronary intervention/ST-segment elevation myocardial infarction引用本文复制引用
Xiao-Si JIANG,Zong-Zhuang LI,Yong-Jun LI,Ren-Qiang YANG,Geng QIAN,Yun-Dai CHEN,Li-Chao TIAN,Zi-Chao JIANG,Yu-Ting ZOU,Ping LI,Xin-Chun YANG,Xi SU,Jin-Wen TIAN,Bei SHI..Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial[J].老年心脏病学杂志(英文版),2020,17(8):519-524,6.基金项目
This study was supported by the National Key Research and Development program of China (2018ZX09201013) and Xinxin Merck Cardiovascular Research Fund (2017-CCA-xinxin merck fund-003).All authors had no conflicts of interest to disclose. (2018ZX09201013)